RADIONUCLIDE INDICATION OF SENTINEL LYMPH NODES IN LARYNX AND LARYNGOPHARYNX CANCER

Aim: to determine the possibility of radionuclide methods in the identification of "sentinel" lymph node (SLN) in larynx and laryngopharynx cancer patients.Material and methods: 17 patients with larynx and laryngopharynx cancer were included in research. In all patients for SLN visualizati...

Full description

Bibliographic Details
Main Authors: I. G. Sinilkin, V. I. Chernov, Ye. L. Choinzonov, S. Yu. Chizhevskaya, A. A. Titskaya, R. V. Zelchan
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2014-02-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/88
_version_ 1827991632640737280
author I. G. Sinilkin
V. I. Chernov
Ye. L. Choinzonov
S. Yu. Chizhevskaya
A. A. Titskaya
R. V. Zelchan
author_facet I. G. Sinilkin
V. I. Chernov
Ye. L. Choinzonov
S. Yu. Chizhevskaya
A. A. Titskaya
R. V. Zelchan
author_sort I. G. Sinilkin
collection DOAJ
description Aim: to determine the possibility of radionuclide methods in the identification of "sentinel" lymph node (SLN) in larynx and laryngopharynx cancer patients.Material and methods: 17 patients with larynx and laryngopharynx cancer were included in research. In all patients for SLN visualization nanocolloid radiopharmaceutical was injection around tumor into mucous coat with the subsequent SPECT and radioguided study.Results: Sensitivity and specificity of SPECT and radioguided study for SLN identification were 100%. We found 22 SLN in 17 patients (from 1 to 2 per patient, on average 1.3). Most often SLN were located in the III level of a neck (lymph nodes around of carotid arteries) – 12 SLN (54.5%) and IIA level (under lower jaw lymph nodes) – 6 (27.2%). One SLN (4.5%) was localized in IV level and 3 nodes (13.6%) in VI level. In 2 patients (11.8%) metastasis in SLN were found. In these patients within 2 years cancer progressing was revealed. Fifteen patients (88.2%) had no metastatic in SLN and had no progressing of a cancer.Conclusions: Sensitivity and specificity of SPECT and radioguided study for SLN identification are 100%. In patients with metastatic SLN radical surgery with lymph node dissection is helpful.
first_indexed 2024-04-10T01:08:18Z
format Article
id doaj.art-0e1cc476e73e4f8ca63d66980a629ad6
institution Directory Open Access Journal
issn 1682-0363
1819-3684
language English
last_indexed 2024-04-10T01:08:18Z
publishDate 2014-02-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj.art-0e1cc476e73e4f8ca63d66980a629ad62023-03-13T09:58:19ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842014-02-0113111612110.20538/1682-0363-2014-1-116-12186RADIONUCLIDE INDICATION OF SENTINEL LYMPH NODES IN LARYNX AND LARYNGOPHARYNX CANCERI. G. Sinilkin0V. I. Chernov1Ye. L. Choinzonov2S. Yu. Chizhevskaya3A. A. Titskaya4R. V. Zelchan5Научно-исследовательский институт онкологии Сибирского отделения РАМН, ТомскНаучно-исследовательский институт онкологии Сибирского отделения РАМН, ТомскНаучно-исследовательский институт онкологии Сибирского отделения РАМН, Томск, Сибирский государственный медицинский университет, ТомскНаучно-исследовательский институт онкологии Сибирского отделения РАМН, ТомскНаучно-исследовательский институт онкологии Сибирского отделения РАМН, ТомскНаучно-исследовательский институт онкологии Сибирского отделения РАМН, ТомскAim: to determine the possibility of radionuclide methods in the identification of "sentinel" lymph node (SLN) in larynx and laryngopharynx cancer patients.Material and methods: 17 patients with larynx and laryngopharynx cancer were included in research. In all patients for SLN visualization nanocolloid radiopharmaceutical was injection around tumor into mucous coat with the subsequent SPECT and radioguided study.Results: Sensitivity and specificity of SPECT and radioguided study for SLN identification were 100%. We found 22 SLN in 17 patients (from 1 to 2 per patient, on average 1.3). Most often SLN were located in the III level of a neck (lymph nodes around of carotid arteries) – 12 SLN (54.5%) and IIA level (under lower jaw lymph nodes) – 6 (27.2%). One SLN (4.5%) was localized in IV level and 3 nodes (13.6%) in VI level. In 2 patients (11.8%) metastasis in SLN were found. In these patients within 2 years cancer progressing was revealed. Fifteen patients (88.2%) had no metastatic in SLN and had no progressing of a cancer.Conclusions: Sensitivity and specificity of SPECT and radioguided study for SLN identification are 100%. In patients with metastatic SLN radical surgery with lymph node dissection is helpful.https://bulletin.ssmu.ru/jour/article/view/88рак гортанирак гортаноглоткисторожевые лимфатические узлы
spellingShingle I. G. Sinilkin
V. I. Chernov
Ye. L. Choinzonov
S. Yu. Chizhevskaya
A. A. Titskaya
R. V. Zelchan
RADIONUCLIDE INDICATION OF SENTINEL LYMPH NODES IN LARYNX AND LARYNGOPHARYNX CANCER
Бюллетень сибирской медицины
рак гортани
рак гортаноглотки
сторожевые лимфатические узлы
title RADIONUCLIDE INDICATION OF SENTINEL LYMPH NODES IN LARYNX AND LARYNGOPHARYNX CANCER
title_full RADIONUCLIDE INDICATION OF SENTINEL LYMPH NODES IN LARYNX AND LARYNGOPHARYNX CANCER
title_fullStr RADIONUCLIDE INDICATION OF SENTINEL LYMPH NODES IN LARYNX AND LARYNGOPHARYNX CANCER
title_full_unstemmed RADIONUCLIDE INDICATION OF SENTINEL LYMPH NODES IN LARYNX AND LARYNGOPHARYNX CANCER
title_short RADIONUCLIDE INDICATION OF SENTINEL LYMPH NODES IN LARYNX AND LARYNGOPHARYNX CANCER
title_sort radionuclide indication of sentinel lymph nodes in larynx and laryngopharynx cancer
topic рак гортани
рак гортаноглотки
сторожевые лимфатические узлы
url https://bulletin.ssmu.ru/jour/article/view/88
work_keys_str_mv AT igsinilkin radionuclideindicationofsentinellymphnodesinlarynxandlaryngopharynxcancer
AT vichernov radionuclideindicationofsentinellymphnodesinlarynxandlaryngopharynxcancer
AT yelchoinzonov radionuclideindicationofsentinellymphnodesinlarynxandlaryngopharynxcancer
AT syuchizhevskaya radionuclideindicationofsentinellymphnodesinlarynxandlaryngopharynxcancer
AT aatitskaya radionuclideindicationofsentinellymphnodesinlarynxandlaryngopharynxcancer
AT rvzelchan radionuclideindicationofsentinellymphnodesinlarynxandlaryngopharynxcancer